Giant Cell Arteritis - Ways to Precision Medicine

Launched by WUERZBURG UNIVERSITY HOSPITAL · Jul 16, 2025

Keywords

ClinConnect Summary

This clinical trial is studying giant cell arteritis (GCA) and polymyalgia rheumatica (PMR), two conditions that cause inflammation and pain, often in older adults. The main goal is to follow patients over time to better understand serious heart and blood vessel problems, as well as side effects from long-term use of steroids, which are commonly used to treat these conditions. This study aims to help doctors find more precise and safer ways to manage GCA and PMR in the future.

Adults aged 18 and older who have been diagnosed with either giant cell arteritis or polymyalgia rheumatica may be eligible to join. Participants will be followed for a long time to monitor their health, especially looking at any heart or blood vessel issues and side effects from steroid treatment. It’s important to note that the trial is not yet recruiting participants, so those interested should keep an eye out for when it begins. People who cannot give informed consent or are under 18 years old will not be able to join this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age greater or similar to 18 years
• • Primary diagnosis of GCA or PMR
• Exclusion Criteria:
• • Age under 18 years
• • lack of capacity to consent